Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

Virpax® Pharmaceuticals, Inc. , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and viral... | March 28, 2023

Related Keywords

California ,United States ,New York ,Fordham University ,Berkeley ,Anthonyp Mack ,Barbaraa Ruskin , ,Whitehead Institute For Biomedical Research ,Exchange Commission ,Jude Children Hospital ,Ip Corporate Partner At Ropes Gray ,Molecular Envelope Technology ,Institute For Neuroscience University Of Oregon ,University Of California ,Board Of The Burke Neurological Institute ,Vertex Pharmaceuticals ,Virpax Pharmaceuticals ,Nasdaq ,Linkedin ,Youtube ,Securities Exchange ,Twitter ,Fish Neave ,Fordham University School Of Law ,Pharmaceuticals Inc ,Harvard University ,Molecular Biology ,Chief Intellectual Property ,Innovation Officer ,Silence Therapeutics ,General Counsel ,Chief Patent ,Stryker Biotech ,Jude Children ,Burke Neurological ,Whitehead Institute ,Biomedical Research ,Fordham University School ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,Company ,Pecializing ,N ,Developing ,Products ,Or ,Rain ,Stress ,Central ,Nervous ,System ,Disorders ,Nd Vrpx Us9282511073 ,